NOxy Health Products, LLC
🇺🇸United States
NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers
Phase 1
Recruiting
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Drug: NOX1416 and SOCProcedure: SOC (Standard of care)
- First Posted Date
- 2024-05-07
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- NOxy Health Products, LLC
- Target Recruit Count
- 40
- Registration Number
- NCT06402565
- Locations
- 🇺🇸
SerenaGroup Omaha, Omaha, Nebraska, United States
🇺🇸SACMH Wound Center, Kittanning, Pennsylvania, United States
🇺🇸SerenaGroup Monroeville, Monroeville, Pennsylvania, United States
NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NTCDU)
Phase 1
Suspended
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Drug: NOX-1416+SOCOther: Placebo+SOC
- First Posted Date
- 2023-08-31
- Last Posted Date
- 2024-01-16
- Lead Sponsor
- NOxy Health Products, LLC
- Target Recruit Count
- 30
- Registration Number
- NCT06020664
- Locations
- 🇮🇱
Soroka Medical Center (Site 106), Beersheba, Israel
🇮🇱Shaare Zedek Hospital (site 101), Jerusalem, Israel
🇮🇱Laniado Hospital (Site 102), Netanya, Israel
© Copyright 2025. All Rights Reserved by MedPath